Measuring the Potential Health Impact of Personalized Medicine: Evidence from MS Treatments

Kristopher J. Hult

NBER Working Paper No. 23900
Issued in October 2017

---- Acknowledgments ----

Thanks for useful comments from the attendees of the Economic Dimensions of Personalized and Precision Medicine conference. The views expressed herein are those of the author and do not necessarily reflect the views of the National Bureau of Economic Research.

return to bibliography page